Neo Biopharm ApS — Credit Rating and Financial Key Figures
CVR number: 42875708
Kildegårdsvej 18 D, 2900 Hellerup
Income statement (kDKK)
2022 | 2023 | |
|---|---|---|
| Fiscal period length | 12 | 12 |
| Net sales | ||
| Gross profit | 2 458.30 | 528.36 |
| EBIT | 2 358.20 | 335.15 |
| Other financial expenses | -16.27 | -19.04 |
| Pre-tax profit | 2 341.93 | 316.12 |
| Income taxes | - 517.02 | -72.31 |
| Net earnings | 1 824.91 | 243.80 |
Assets (kDKK)
2022 | 2023 | |
|---|---|---|
| Intangible assets total | ||
| Tangible assets total | ||
| Investments total | ||
| Long term receivables total | ||
| Inventories total | ||
| Current trade debtors | 472.86 | |
| Current other receivables | 49.66 | 58.98 |
| Current deferred tax assets | 0.70 | |
| Short term receivables total | 523.22 | 58.98 |
| Cash and bank deposits | 2 069.43 | 2 686.29 |
| Cash and cash equivalents | 2 069.43 | 2 686.29 |
| Balance sheet total (assets) | 2 592.65 | 2 745.27 |
Equity and liabilities (kDKK)
2022 | 2023 | |
|---|---|---|
| Share capital | 40.00 | 40.00 |
| Retained earnings | 1 824.91 | |
| Profit of the financial year | 1 824.91 | 243.80 |
| Shareholders equity total | 1 864.91 | 2 108.71 |
| Non-current liabilities total | ||
| Current trade creditors | 206.34 | 564.25 |
| Current owed to participating | 4.38 | |
| Short-term deferred tax liabilities | 517.02 | 72.31 |
| Current liabilities total | 727.74 | 636.56 |
| Balance sheet total (liabilities) | 2 592.65 | 2 745.27 |
Try the full version of our system for free
Create your own estimates for any company
Valuation analysis
See instructions
... and more!
No registration needed.